Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Biosimilars [Design Issues]

posted by M.Vasu – India, 2011-11-24 15:01 (4969 d 14:05 ago) – Posting: # 7712
Views: 8,575

Hi,

Can any one explain regarding BE study procedure for Biosimilars (Injection) in healthy subjets?

Thanks,

VM..........

Edit: Category changed. [Helmut]

Complete thread:

BiosimilarsM.Vasu 2011-11-24 14:01 [Design Issues]
- Biosimilars Helmut 2011-11-24 14:44
  - Biosimilars M.Vasu 2011-11-28 12:33
    - Healthy subjects vs. patients Helmut 2011-11-28 12:56
    - Biosimilars drgunasakaran1 2012-02-06 13:57
  - Biosimilars Ben 2011-12-16 19:04
- Biosimilars Chiku 2012-02-03 06:43
  - Biosimilars drgunasakaran1 2012-02-10 11:33
    - Biosimilars Chiku 2012-02-10 12:03
      - Biosimilars Kumarnaidu2 2021-10-22 07:53

Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
66 visitors (0 registered, 66 guests [including 9 identified bots]).
Forum time: 06:07 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do. Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz